Bernhard Janke

Bernhard Janke is a Partner at 468 Capital, a venture capital firm located in Berlin and San Francisco, since October 2021. Janke holds multiple investor roles across various companies, including Zellerfeld Shoe Company Inc., Cartken, ParcelBio, Tamarind Bio, Relari, YonedaLabs, Velorum Therapeutics (YC W24), ego (YC W24), and acto, with investments starting from April and June 2024. Janke has a strong academic background with a Master’s Degree and a Bachelor’s Degree in Industrial Engineering from the Karlsruhe Institute of Technology (KIT), earned between 2007 and 2013.